Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness

The genetic lesions identified in chronic lymphocytic leukemia (CLL) do not entirely recapitulate the disease pathogenesis and the development of serious complications, such as chemorefractoriness. While investigating the coding genome of fludarabine-refractory CLL, we observed that mutations of SF3...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Rossi, Davide, Bruscaggin, Alessio, Spina, Valeria, Rasi, Silvia, Khiabanian, Hossein, Messina, Monica, Fangazio, Marco, Vaisitti, Tiziana, Monti, Sara, Chiaretti, Sabina, Guarini, Anna, Del Giudice, Ilaria, Cerri, Michaela, Cresta, Stefania, Deambrogi, Clara, Gargiulo, Ernesto, Gattei, Valter, Forconi, Francesco, Bertoni, Francesco, Deaglio, Silvia, Rabadan, Raul, Pasqualucci, Laura, Foà, Robin, Dalla-Favera, Riccardo, Gaidano, Gianluca
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2011
Teme:
Clinical Trials and Observations
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3245210/
https://ncbi.nlm.nih.gov/pubmed/22039264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-08-373159
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items